Novartis
NVS
NVS
908 hedge funds and large institutions have $19.9B invested in Novartis in 2017 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 342 increasing their positions, 334 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
908
Holders Change
+5
Holders Change %
+0.55%
% of All Funds
22.64%
Holding in Top 10
20
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-4.76%
% of All Funds
0.5%
New
76
Increased
342
Reduced
334
Closed
61
Calls
$30.9M
Puts
$68.2M
Net Calls
-$37.3M
Net Calls Change
-$54.7M
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
+$361M |
| 2 |
Parnassus Investments
San Francisco,
California
|
+$280M |
| 3 |
BlackRock
New York
|
+$210M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$130M |
| 5 |
Millennium Management
New York
|
+$102M |
Top Sellers
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$239M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$104M |
| 3 |
ClearBridge Investments
New York
|
-$81.4M |
| 4 |
Lazard Asset Management
New York
|
-$47.6M |
| 5 |
MHI
Miller Howard Investments
Kingston,
New York
|
-$46.6M |